1. Home
  2. CSBR vs LODE Comparison

CSBR vs LODE Comparison

Compare CSBR & LODE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • LODE
  • Stock Information
  • Founded
  • CSBR 1985
  • LODE 2008
  • Country
  • CSBR United States
  • LODE United States
  • Employees
  • CSBR N/A
  • LODE N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • LODE Major Chemicals
  • Sector
  • CSBR Health Care
  • LODE Industrials
  • Exchange
  • CSBR Nasdaq
  • LODE Nasdaq
  • Market Cap
  • CSBR 98.1M
  • LODE 79.6M
  • IPO Year
  • CSBR 1986
  • LODE N/A
  • Fundamental
  • Price
  • CSBR $7.55
  • LODE $0.34
  • Analyst Decision
  • CSBR Strong Buy
  • LODE Buy
  • Analyst Count
  • CSBR 1
  • LODE 1
  • Target Price
  • CSBR $8.00
  • LODE $2.60
  • AVG Volume (30 Days)
  • CSBR 61.8K
  • LODE 4.5M
  • Earning Date
  • CSBR 12-11-2024
  • LODE 10-22-2024
  • Dividend Yield
  • CSBR N/A
  • LODE N/A
  • EPS Growth
  • CSBR N/A
  • LODE N/A
  • EPS
  • CSBR N/A
  • LODE N/A
  • Revenue
  • CSBR $53,571,000.00
  • LODE $1,864,811.00
  • Revenue This Year
  • CSBR $14.19
  • LODE $80.00
  • Revenue Next Year
  • CSBR $10.11
  • LODE $47.60
  • P/E Ratio
  • CSBR N/A
  • LODE N/A
  • Revenue Growth
  • CSBR 7.19
  • LODE 117.46
  • 52 Week Low
  • CSBR $3.60
  • LODE $0.13
  • 52 Week High
  • CSBR $7.85
  • LODE $0.72
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 71.57
  • LODE 43.77
  • Support Level
  • CSBR $4.61
  • LODE $0.28
  • Resistance Level
  • CSBR $7.85
  • LODE $0.41
  • Average True Range (ATR)
  • CSBR 0.75
  • LODE 0.05
  • MACD
  • CSBR 0.26
  • LODE -0.01
  • Stochastic Oscillator
  • CSBR 81.84
  • LODE 23.29

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About LODE Comstock Inc.

Comstock Inc is engaged in technologies that efficiently use wasted and under-utilized natural resources to produce renewable energy and other products that contribute to balancing uses and emissions of carbon and enhance mineral and material discoveries. The segments of the company are Fuels Metals, Mining, Strategic Investments, and Corporate. The company derives maximum revenue from Strategic Investments segment. The Strategic Investments Segment includes minority equity investments in Quantum Generative Materials LLC (physics-based artificial intelligence), Green Li-ion Pte Limited (lithium-ion battery recycling and cathode production), Sierra Springs Opportunity Fund (strategic direct investment in northern Nevada real estate), and other equity or equity-linked investments.

Share on Social Networks: